AKSO HEALTH GR. (SPADR)/3 Total Assets
AKSO HEALTH GR. (SPADR)/3 total assets. Based on the latest financial reports, AKSO HEALTH GR. (SPADR)/3 (8HX) holds total assets worth €212.04 Million EUR (≈ $247.90 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see cash efficiency ratio of AKSO HEALTH GR. (SPADR)/3 for how efficiently the company converts equity into cash flow.
Total Assets of AKSO HEALTH GR. (SPADR)/3 (2022–2025)
Total assets of AKSO HEALTH GR. (SPADR)/3 from 2022 to 2025. This chart illustrates how AKSO HEALTH GR. (SPADR)/3's total assets have evolved over time, based on quarterly financial data. See AKSO HEALTH GR. (SPADR)/3 (8HX) stock price for real-time trading data and today's change.
AKSO HEALTH GR. (SPADR)/3 - Asset Composition Analysis
AKSO HEALTH GR. (SPADR)/3 Total Assets Breakdown (March 2025)
AKSO HEALTH GR. (SPADR)/3 total assets breakdown as of March 2025. AKSO HEALTH GR. (SPADR)/3's total assets of €212.04 Million consist of 91.2% current assets and 8.8% non-current assets. Explore working capital position of AKSO HEALTH GR. (SPADR)/3 to assess how much short-term liquidity the company maintains relative to its equity base.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 82.0% |
| Accounts Receivable | €954.20K | 0.4% |
| Inventory | €190.24K | 0.1% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €7.88 Million | 3.7% |
| Goodwill | €10.83 Million | 5.0% |
Asset Composition Trend (2022–2025)
This chart illustrates how AKSO HEALTH GR. (SPADR)/3's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: AKSO HEALTH GR. (SPADR)/3's current assets represent 91.2% of total assets in 2025, a decrease from 99.7% in 2022.
- Cash Position: Cash and equivalents constituted 82.0% of total assets in 2025, up from 29.3% in 2022.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, an increase from 0.0% in 2022.
- Asset Diversification: The largest asset category is goodwill at 5.0% of total assets.
AKSO HEALTH GR. (SPADR)/3 Competitors by Total Assets
Key competitors of AKSO HEALTH GR. (SPADR)/3 based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Hanmi Science
KO:008930
|
Korea | ₩1.49 Trillion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
TELES Informationstechnologien AG
XETRA:TLIK
|
Germany | €4.29 Million |
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$8.80 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$5.64 Billion |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
|
China | CN¥240.77 Billion |
AKSO HEALTH GR. (SPADR)/3 - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.53 | 8.19 | 8.19 |
| Quick Ratio | 1.51 | 8.18 | 8.18 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €6.37 Million | €87.98 Million | €87.98 Million |
AKSO HEALTH GR. (SPADR)/3 - Advanced Valuation Insights
This section examines the relationship between AKSO HEALTH GR. (SPADR)/3's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.46 |
| Latest Market Cap to Assets Ratio | 7.45 |
| Asset Growth Rate (YoY) | 51.4% |
| Total Assets | €214.95 Million |
| Market Capitalization | $1.60 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values AKSO HEALTH GR. (SPADR)/3's assets at a significant premium (7.45x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: AKSO HEALTH GR. (SPADR)/3's assets grew by 51.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for AKSO HEALTH GR. (SPADR)/3 (2022–2025)
The table below shows the annual total assets of AKSO HEALTH GR. (SPADR)/3 from 2022 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | €214.95 Million ≈ $251.30 Million |
+51.36% |
| 2024-03-31 | €142.02 Million ≈ $166.03 Million |
+594.12% |
| 2023-03-31 | €20.46 Million ≈ $23.92 Million |
-67.42% |
| 2022-03-31 | €62.81 Million ≈ $73.43 Million |
-- |
About AKSO HEALTH GR. (SPADR)/3
Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. The compan… Read more